You are here

  • Home
  • Archive
  • Volume 9, Issue 11
  • Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

Article info

Article menu
Clinical/translational cancer immunotherapy
Original research
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis

Authors

  • Yifei Ma Department of Orthopedics & Spine Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, People's Republic of China PubMed articlesGoogle scholar articles
  • Nianqi Liu Lab for Post-traumatic Stress Disorder, Faculty of Psychology and Mental Health, Naval Medical University, Shanghai, People's Republic of China The Emotion & Cognition Lab, Faculty of Psychology and Mental Health, Naval Medical University, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Youlong Wang Department of General Surgery, Hainan Hospital of PLA General Hospital, Sanya City, Hainan Province, People's Republic of China PubMed articlesGoogle scholar articles
  • Jiling Zeng Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China PubMed articlesGoogle scholar articles
  • Ying-Ying Hu Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China PubMed articlesGoogle scholar articles
  • Wu Hao Department of Breast Oncology, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China PubMed articlesGoogle scholar articles
  • Huazheng Shi Department of Nuclear Medicine, Shanghai Universal Medical Imaging Center, Shanghai, People's Republic of China PubMed articlesGoogle scholar articles
  • Pengfei Zhu Department of Clinical Laboratory, Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, People's Republic of China PubMed articlesGoogle scholar articles
  • Jun Lv Department of Infectious Diseases and Hepatology, Zhengzhou University First Affiliated Hospital, Zhengzhou, Henan, People's Republic of China PubMed articlesGoogle scholar articles
  • Wei Fan Department of Nuclear Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China PubMed articlesGoogle scholar articles
  • Xinjia Wang Department of Orthopedics & Spine Surgery, Second Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, People's Republic of China Department of Orthopedics, Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, People's Republic of China PubMed articlesGoogle scholar articles

Citation

Ma Y, Liu N, Wang Y, et al
Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis
Journal for ImmunoTherapy of Cancer 2021;9:e003712. doi: 10.1136/jitc-2021-003712
Online issue publication 
May 08, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.